Vincristine
Top View
- Chemotherapy Extravasation Management
- Evolution of Nitrogen-Based Alkylating Anticancer Agents
- In Vitro and in Vivo Characterization of Doxorubicin and Vincristine
- MS-209, a Quinoline-Type Reversal Agent, Potentiates Antitumor Efficacy of Docetaxel in Multidrug-Resistant Solid Tumor Xenograft Models1
- Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies
- Estramustine Phosphate Induces PC3 Apoptosis in Prostate Cancer Occurrence and Development
- Pharmacokinetics of Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia
- HOPA News Volume 10, Issue 1
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
- Hospira UK Ltd Queensway, Royal Leamington Spa, Warwickshire
- BC Cancer Protocol Summary for Etoposide, Ifosfamide-Mesna
- Effects of Vincristine in Combination with Methotrexate and Other Antitumor Agents in Human Acute Lymphoblastic Leukemia Cells in Culture1
- Full Text (PDF)
- RCEOP-Cyclophosphamide-Etoposide-Prednisolone-Rituximab-Vincristine Ver
- Neulasta and Pegfilgrastim Biosimilars 1931-A SGM P2020 © 2020 CVS Caremark
- 1 Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor
- Schedule-Dependent Synergism and Antagonism Between Methotrexate
- Optimum Time Sequence for the Administration of Vincristine and Cyclophosphamide in Vivo1